Febrile seizure during treatment with methylphenidate

Abstract

Methylphenidate (MPH) is the main psychostimulant drug for children and adolescents with ADHD. The long-acting stimulant of osmotic controlled-release oral delivery system (OROS) MPH has been designed to release gradually increasing concentrations of MPH over a period of 10-12 hours. Febrile seizure (FS) is a seizure associated with high body temperature, typically due to a viral infection. In this case report, a 17year-old boy with a history of ADHD who experienced a febrile seizure while taking OROS-MPH is reported.